Tag: Xembify

According to the official XEMBIFY website, most patients or caregivers can be trained to infuse the medication at home. The answer to "Can xembify be self-administered?" is yes, but it is contingent upon receiving proper self-infusion training from a healthcare professional.

Xembify is a 20% subcutaneous immune globulin (SCIG) replacement therapy approved for treating primary humoral immunodeficiency disease (PI) in patients aged 2 and older. For most patients, this treatment is administered at home following training from a healthcare professional. This guide will detail exactly how is Xembify administered, ensuring a safe and effective self-infusion process.